News about "good manufacturing practice (GMP)"

Piramal Pharma Opens New Microbiology Lab in Kentucky

Piramal Pharma Opens New Microbiology Lab in Kentucky

Piramal Pharma Solutions has launched a new microbiology lab and sterility testing suite at its Lexington, Kentucky facility for GMP drug product applications.

Good Manufacturing Practice (GMP) | 08/10/2026 | By News Bureau

Piramal Pharma Acquires 40.67 Percent Additional Stake in Yapan Bio for INR 76 Crore

Piramal Pharma Acquires 40.67 Percent Additional Stake in Yapan Bio for INR 76 Crore

Piramal Pharma acquires an additional 40.67 percent stake in Yapan Bio for INR 76 crore, raising its ownership to 74 percent and expanding its biologics Contract Development and Manufacturing Organisation (CDMO) capabilities.

Good Manufacturing Practice (GMP) | 18/08/2026 | By News Bureau |  146

Gland Pharma and Neuland Partner for Sterile API Manufacturing

Gland Pharma and Neuland Partner for Sterile API Manufacturing

Gland Pharma and Neuland Laboratories have partnered to expand sterile Active Pharmaceutical Ingredient (API) manufacturing through a new state-of-the-art current Good Manufacturing Practice (GMP) sterile manufacturing suite.

Good Manufacturing Practice (GMP) | 06/08/2026 | By News Bureau |  101

Cipla's InvaGen Receives US FDA EIR for New York Manufacturing Facility

Cipla's InvaGen Receives US FDA EIR for New York Manufacturing Facility

Cipla's subsidiary InvaGen has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (FDA), marking the successful closure of the inspection at its New York facility.

Good Manufacturing Practice (GMP) | 04/08/2026 | By News Bureau |  135

NMPA Reviews QMS for Vaccine and Drug GMP Compliance

NMPA Reviews QMS for Vaccine and Drug GMP Compliance

China's NMPA has completed a QMS management review to strengthen vaccine and drug Good Manufacturing Practice (GMP) compliance, supporting WHO WLA standards and PIC/S regulatory requirements.

Good Manufacturing Practice (GMP) | 13/07/2026 | By News Bureau |  113

PharmAla Completes GMP Manufacturing for ALA-002

PharmAla Completes GMP Manufacturing for ALA-002

PharmAla has completed GMP manufacturing of ALA-002 drug substance components and is preparing to begin GMP drug product manufacturing for upcoming global clinical trials.

Good Manufacturing Practice (GMP) | 07/07/2026 | By News Bureau |  114

EDQM Audit Finds Anuh Pharma Facility Compliant

EDQM Audit Finds Anuh Pharma Facility Compliant

Anuh Pharma has cleared a Good Manufacturing Practice (GMP) milestone following a successful audit by the European Directorate for the Quality of Medicines & HealthCare at its bulk drug manufacturing facility in Tarapur, Maharashtra, the company said in a stock exchange filing.

Good Manufacturing Practice (GMP) | 11/03/2026 | By News Bureau |  184

WuXi Biologics' Wuxi Facilities Receive MHRA GMP Approval for Ophthalmic Biologic Manufacturing

WuXi Biologics' Wuxi Facilities Receive MHRA GMP Approval for Ophthalmic Biologic Manufacturing

The UK regulator has certified WuXi Biologics’ DP5 and DPPC sites in Wuxi for commercial production, reinforcing the company’s global GMP-compliant manufacturing capabilities.

Good Manufacturing Practice (GMP) | 13/01/2026 | By News Bureau |  289

USFDA Concludes Inspection at Dr. Reddy's Srikakulam Facility with VAI Classification

USFDA Concludes Inspection at Dr. Reddy's Srikakulam Facility with VAI Classification

Dr. Reddy’s Laboratories has announced that the United States Food and Drug Administration (USFDA) has completed a Good Manufacturing Practice (GMP) and Pre-Approval Inspection (PAI) at its formulations manufacturing facility (FTO 11) in Srikakulam, Andhra Pradesh.

Good Manufacturing Practice (GMP) | 21/10/2025 | By Dineshwori |  552

Biocon's Cranbury Facility in US Passes FDA Inspection, Supports Expansion Plans

Biocon's Cranbury Facility in US Passes FDA Inspection, Supports Expansion Plans

Biocon’s inspection concluded with a single observation, which the company will address within the stipulated timeframe, and it is not expected to impact ongoing business operations

Good Manufacturing Practice (GMP) | 15/10/2025 | By Dineshwori |  311


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members